IOL CHEMICALS & PHARM. | GODAVARI DRU | IOL CHEMICALS & PHARM./ GODAVARI DRU |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 17.8 | 74.2% | View Chart |
P/BV | x | 1.5 | 2.2 | 66.9% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. GODAVARI DRU |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
GODAVARI DRU Mar-23 |
IOL CHEMICALS & PHARM./ GODAVARI DRU |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 102 | 526.2% | |
Low | Rs | 272 | 52 | 523.5% | |
Sales per share (Unadj.) | Rs | 377.6 | 212.0 | 178.1% | |
Earnings per share (Unadj.) | Rs | 23.7 | 5.0 | 471.4% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 7.6 | 414.8% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 44.4 | 578.7% | |
Shares outstanding (eoy) | m | 58.71 | 7.53 | 779.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.4 | 294.8% | |
Avg P/E ratio | x | 17.1 | 15.3 | 111.4% | |
P/CF ratio (eoy) | x | 12.8 | 10.1 | 126.6% | |
Price / Book Value ratio | x | 1.6 | 1.7 | 90.8% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 580 | 4,094.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 48 | 3,475.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 1,596 | 1,388.9% | |
Other income | Rs m | 256 | 7 | 3,909.9% | |
Total revenues | Rs m | 22,427 | 1,603 | 1,399.3% | |
Gross profit | Rs m | 2,257 | 102 | 2,223.3% | |
Depreciation | Rs m | 462 | 19 | 2,374.5% | |
Interest | Rs m | 165 | 39 | 419.4% | |
Profit before tax | Rs m | 1,887 | 49 | 3,822.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 11 | 4,309.0% | |
Profit after tax | Rs m | 1,391 | 38 | 3,675.1% | |
Gross profit margin | % | 10.2 | 6.4 | 160.1% | |
Effective tax rate | % | 26.2 | 23.3 | 112.7% | |
Net profit margin | % | 6.3 | 2.4 | 264.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 870 | 1,111.0% | |
Current liabilities | Rs m | 5,025 | 737 | 681.8% | |
Net working cap to sales | % | 20.9 | 8.3 | 251.3% | |
Current ratio | x | 1.9 | 1.2 | 163.0% | |
Inventory Days | Days | 43 | 1 | 4,282.5% | |
Debtors Days | Days | 8 | 1,325 | 0.6% | |
Net fixed assets | Rs m | 11,017 | 344 | 3,200.2% | |
Share capital | Rs m | 587 | 75 | 779.6% | |
"Free" reserves | Rs m | 14,490 | 259 | 5,597.4% | |
Net worth | Rs m | 15,077 | 334 | 4,511.8% | |
Long term debt | Rs m | 0 | 119 | 0.0% | |
Total assets | Rs m | 20,684 | 1,214 | 1,703.3% | |
Interest coverage | x | 12.5 | 2.3 | 551.9% | |
Debt to equity ratio | x | 0 | 0.4 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.3 | 81.5% | |
Return on assets | % | 7.5 | 6.4 | 118.4% | |
Return on equity | % | 9.2 | 11.3 | 81.5% | |
Return on capital | % | 13.6 | 19.5 | 69.6% | |
Exports to sales | % | 26.7 | 0.4 | 6,275.0% | |
Imports to sales | % | 0 | 60.3 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 7 | 87,207.4% | |
Imports (cif) | Rs m | NA | 962 | 0.0% | |
Fx inflow | Rs m | 5,930 | 7 | 87,207.4% | |
Fx outflow | Rs m | 6,052 | 963 | 628.4% | |
Net fx | Rs m | -122 | -956 | 12.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 132 | 925.1% | |
From Investments | Rs m | -1,200 | -86 | 1,389.0% | |
From Financial Activity | Rs m | -41 | -38 | 109.0% | |
Net Cashflow | Rs m | -18 | 8 | -227.7% |
Indian Promoters | % | 48.2 | 53.2 | 90.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.5 | 340.0% | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 46.8 | 110.6% | |
Shareholders | 130,003 | 7,005 | 1,855.9% | ||
Pledged promoter(s) holding | % | 0.0 | 1.3 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | GODAVARI DRU | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.10% | 2.47% | -0.44% |
1-Month | -4.43% | 6.36% | 2.15% |
1-Year | -4.01% | 28.34% | 49.82% |
3-Year CAGR | -11.98% | 23.93% | 14.21% |
5-Year CAGR | 15.37% | 34.61% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the GODAVARI DRU share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of GODAVARI DRU the stake stands at 53.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of GODAVARI DRU.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
GODAVARI DRU paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of GODAVARI DRU.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.